The private sector added 86,000 jobs in October, exceeding economists' expectations of 69,000 and matching the revised figure from the previous month. Employers across all sizes contributed to this growth, with job-changers benefiting from bonuses, overtime, and higher base pay, leading to the fastest earnings growth since March 2024. Meanwhile, historical trends suggest the stock market will be higher in 12 months following midterm elections, continuing a pattern seen since World War II. This combination of strong job growth and positive market outlook signals improving economic conditions ahead.
Private sector job growth is the subject, with Pluang market data providing context. For readers following US stocks, here is Pluang's market snapshot as of Nov 04, 2026 22:02 WIB: Out of 150 priced stocks, 124 rose and 26 fell. Notable movers include LCID at USD 3.46 (+14.40%), XYZ at USD 86.55 (+13.93%) with 100% sell orders, and LYFT at USD 18.48 (+10.86%).
The global AI accelerator market is projected to grow from $151 billion in 2025 to $443 billion by 2030, with a compound annual growth rate of about 24%. This expansion is fueled by the rise of generative AI, large language models, and increased inve...
No7 Software has enhanced its Anchor Loyalty & Rewards app by integrating Shopify POS, allowing merchants to run a unified loyalty program across online stores and physical shops. Customers now maintain a single points balance, tier status, and refer...
A growing town replaced its inefficient IT request process of spreadsheets and emails with a centralized Microsoft Power Apps hub developed by eSoftware Associates. This hub integrates project intake, risk assessment, and PMO scoring into one platfor...
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
